Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_assertion type Assertion NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_head.
- NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_assertion description "[On the other hand, our data indicate that the K-RAS mutational status of the primary tumor does not predict the status of the bone metastatic tissue of NSCLC, since we have observed both emergence of mutant clones in metastases from wild-type (wt) primary tumors and loss of mutant clones in metastases from mutant primaries in addition to the maintained mutant status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_provenance.
- NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_assertion evidence source_evidence_literature NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_provenance.
- NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_assertion SIO_000772 17607370 NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_provenance.
- NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_assertion wasDerivedFrom befree-20140225 NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_provenance.
- NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_assertion wasGeneratedBy ECO_0000203 NP536421.RAyf_Pirbm0D1FpIbo7dTvpF8Q-ERHus9269QASfLPYec130_provenance.